Home  /  Resource Library  /  Allo-HSCT May Be Effective for Patients With Hepatosplenic T-Cell Lymphoma

Allo-HSCT May Be Effective for Patients With Hepatosplenic T-Cell Lymphoma

Transplantation and Cellular Therapy 2022: Study investigated the use of allogeneic stem cell transplants as treatment for hepatosplenic T-cell lymphoma.